Dr Anna Lavelle

Dr Anna Lavelle

Bid wins:
Agricultural Bioscience International Conference (ABIC)
6-9 September 2015

International Biotechnology Symposium and Exhibition (IBS)
24-27 October 2016

About:
Dr Anna Lavelle is the newest Chair of Medicines Australia. She was appointed inaugural Chief Executive Officer and Executive Director of AusBiotech Ltd in June 2005.  AusBiotech is Australia’s industry body for life sciences, with over 3,000 members. Dr Lavelle is also a Director on the Boards of Research Australia, the Agricultural Biotechnology Council of Australia and the Advisory Board for the School of Biological Sciences at Monash University. Dr Lavelle has also Chaired, or has been a member of various Federal and State government committees associated with biotechnology. Previous appointments have included the Victorian Biotechnology Advisory Council and the Pharmaceuticals Industry Strategy Group (state and federal Ministerial appointments, respectively). Dr Lavelle holds a Doctor of Philosophy in Genetics from the University of Melbourne, is an Australian Academy of Technological Sciences and Engineering Fellow (as well sitting on various ATSE selection committees) and is a graduate of the Australian Institute of Company Directors, including their ‘Mastering the Boardroom’ program.

Learn more about this Ambassador.